Väljaminev kiriAvalik
Vastus pöördumisele
Sotsiaalministeerium · 2. september 2021
- Viit
- 1.5-1.1/2579-2
- Registreeritud
- 2. september 2021
- Dokumendi liik
- Väljaminev kiri
- Adressaat
- New Frontier Data
- Saabumis/saatmisviis
- Outlook
- Funktsioon
- 1.5 Asjaajamine. Info- ja kommunikatsioonitehnoloogia arendus ja haldus
- Sari
- 1.5-1.1 Teabenõuded, märgukirjad, selgitustaotlused
- Toimik
- 1.5-1.1/2021
- Vastutaja
- Anna-Liisa Uisk (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Rahvatervise osakond)
Failid
Sisu (failidest)
Saatja: Anna-Liisa Uisk </o=JM/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=user5682285f>
Saaja: '[email protected]'
Teema: RE: Data request
Dear Sir/Madam,
I am writing to answer Your data request concerning the use of medical cannabis in Estonia.
Cannabis as a herb can not be used for medical purposes in Estonia. It is possible to use cannabis based medicines (e. g Sativex, Epidyolex). According to the Agency of Medicines there has been one patient who has been prescribed Sativex and 5 patients are using Epidyolex in Estonia.
Based on the Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof (https://www.riigiteataja.ee/en/eli/523012020001/consolide) the THC % limit that separates psychoactive from non-psychoactive cannabis in Estonia is 0,2%.
With regards
Anna-Liisa Uisk
Adviser | Public Health Department
+372 626 9163 | [email protected] <mailto:[email protected]>
Ministry of Social Affairs
Suur-Ameerika 1 | 10122 Tallinn
Estonia
+372 626 9301 | http://www.sm.ee <http://www.sm.ee/et>